BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 34758719)

  • 1. The Influence of Wuzhi Capsule on the Pharmacokinetics of Cyclophosphamide.
    Chen L; Ji N; Zhang M; Chen W
    Recent Pat Anticancer Drug Discov; 2022; 17(2):195-203. PubMed ID: 34758719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Pharmacokinetic Prediction of Cyclosporin A after Coadministration with Wuzhi Capsule.
    Fan J; Chen L; Lu X; Li M; Zhu L
    AAPS PharmSciTech; 2019 Jul; 20(6):247. PubMed ID: 31286321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the Impact of
    He Q; Bu F; Zhang H; Wang Q; Tang Z; Yuan J; Lin HS; Xiang X
    Pharmaceuticals (Basel); 2021 Feb; 14(3):. PubMed ID: 33673653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of Drug-Drug Interaction between Tacrolimus and Principal Ingredients of Wuzhi Capsule in Chinese Healthy Volunteers Using Physiologically-Based Pharmacokinetic Modelling.
    Zhang H; Bu F; Li L; Jiao Z; Ma G; Cai W; Zhuang X; Lin HS; Shin JG; Xiang X
    Basic Clin Pharmacol Toxicol; 2018 Mar; 122(3):331-340. PubMed ID: 28945011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of traditional chinese medicine Wuzhi capsule on pharmacokinetics of tacrolimus in rats.
    Wei H; Tao X; Di P; Yang Y; Li J; Qian X; Feng J; Chen W
    Drug Metab Dispos; 2013 Jul; 41(7):1398-403. PubMed ID: 23628674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wuzhi capsule regulates chloroacetaldehyde pharmacokinetics behaviour and alleviates high-dose cyclophosphamide-induced nephrotoxicity and neurotoxicity in rats.
    Chen L; Xiong X; Hou X; Wei H; Zhai J; Xia T; Gong X; Gao S; Feng G; Tao X; Zhang F; Chen W
    Basic Clin Pharmacol Toxicol; 2019 Aug; 125(2):142-151. PubMed ID: 30793490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schisandra chinensis extract decreases chloroacetaldehyde production in rats and attenuates cyclophosphamide toxicity in liver, kidney and brain.
    Zhai J; Zhang F; Gao S; Chen L; Feng G; Yin J; Chen W
    J Ethnopharmacol; 2018 Jan; 210():223-231. PubMed ID: 28821392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP2C19 is involved in the effect of Wuzhi tablet (
    Yuan F; Liang X; Chen X; Qin X; Tan C; Wang L
    Pharmazie; 2020 Nov; 75(11):559-564. PubMed ID: 33239129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetic analysis and dosing guidelines for tacrolimus co-administration with Wuzhi capsule in Chinese renal transplant recipients.
    Jing Y; Kong Y; Hou X; Liu H; Fu Q; Jiao Z; Peng H; Wei X
    J Clin Pharm Ther; 2021 Aug; 46(4):1117-1128. PubMed ID: 33768546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Influence of Different Triazole Antifungal Agents on the Pharmacokinetics of Cyclophosphamide.
    Cai T; Liao Y; Chen Z; Zhu Y; Qiu X
    Ann Pharmacother; 2020 Jul; 54(7):676-683. PubMed ID: 31893943
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of Wuzhi tablet (Schisandra sphenanthera extract) on the pharmacokinetics of cyclosporin A in rats.
    Xue XP; Qin XL; Xu C; Zhong GP; Wang Y; Huang M; Bi HC
    Phytother Res; 2013 Aug; 27(8):1255-9. PubMed ID: 22996305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial dose optimization of tacrolimus for children with systemic lupus erythematosus based on the CYP3A5 polymorphism and coadministration with Wuzhi capsule.
    Chen X; Wang D; Xu H; Li Z
    J Clin Pharm Ther; 2020 Apr; 45(2):309-317. PubMed ID: 31755126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wuzhi Capsule Dosage Affects Tacrolimus Elimination in Adult Kidney Transplant Recipients, as Determined by a Population Pharmacokinetics Analysis.
    Chen L; Yang Y; Wang X; Wang C; Lin W; Jiao Z; Wang Z
    Pharmgenomics Pers Med; 2021; 14():1093-1106. PubMed ID: 34511980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-administration of Wuzhi tablet (Schisandra sphenanthera extract) alters tacrolimus pharmacokinetics in a dose- and time-dependent manner in rats.
    Qin XL; Li JL; Wang SH; Chen X; Huang M; Bi HC
    J Ethnopharmacol; 2020 Dec; 263():113233. PubMed ID: 32768638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wuzhi capsule increased systemic exposure to methotrexate by inhibiting the expression of OAT1/3 and P-gp.
    Fu R; Wang XN; Guo CH; Li Y; Ding CY; Li YJ; Dong ZJ
    Ann Transl Med; 2021 May; 9(10):845. PubMed ID: 34164479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Tacrolimus on the pharmacokinetics of bioactive lignans of Wuzhi tablet (Schisandra sphenanthera extract) and the potential roles of CYP3A and P-gp.
    Qin XL; Chen X; Zhong GP; Fan XM; Wang Y; Xue XP; Wang Y; Huang M; Bi HC
    Phytomedicine; 2014 Apr; 21(5):766-72. PubMed ID: 24462213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiologically Based Pharmacokinetic Modelling of Hyperforin to Predict Drug Interactions with St John's Wort.
    Adiwidjaja J; Boddy AV; McLachlan AJ
    Clin Pharmacokinet; 2019 Jul; 58(7):911-926. PubMed ID: 30675694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Wuzhi tablet (Schisandra sphenanthera extract) on the pharmacokinetics of paclitaxel in rats.
    Jin J; Bi H; Hu J; Zeng H; Zhong G; Zhao L; Huang Z; Huang M
    Phytother Res; 2011 Aug; 25(8):1250-3. PubMed ID: 21796700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of a "Fit for Purpose" PBPK Model to Investigate the CYP3A4 Induction Potential of Enzalutamide.
    Narayanan R; Hoffmann M; Kumar G; Surapaneni S
    Drug Metab Lett; 2016; 10(3):172-179. PubMed ID: 27604990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of initial dosing scheme of tacrolimus in pediatric refractory nephrotic syndrome patients based on CYP3A5 genotype and coadministration with wuzhi-capsule.
    Chen X; Wang DD; Xu H; Li ZP
    Xenobiotica; 2020 May; 50(5):606-613. PubMed ID: 31530218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.